Jafron Biomedical Co. Ltd. | Ownership
Companies that own Jafron Biomedical Co. Ltd.
Guangzhou Xuan Yuan Investment Management Co., Ltd.
3,260,000
3.08%
3,260,000
11.79%
12/31/2017
Fullgoal Fund Management Co., Ltd.
2,099,921
1.99%
2,099,921
0.13%
12/31/2017
ICBC Credit Suisse Asset Management Co., Ltd.
1,261,912
1.19%
1,261,912
0.11%
12/31/2017
China Galaxy Investment Management Co., Ltd.
1,154,100
1.09%
1,154,100
18.91%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
460,181
0.44%
384,799
0.19%
12/31/2017
Harvest Fund Management Co., Ltd.
390,000
0.37%
390,000
0.02%
12/31/2017
China Universal Asset Management Co., Ltd.
239,400
0.23%
235,100
0.01%
12/31/2017
First State Cinda Fund Management Co. Ltd.
207,714
0.2%
207,714
0.2%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
195,202
0.19%
115,200
0.04%
12/31/2017
GF Fund Management Co., Ltd.
133,899
0.13%
90,799
0.01%
12/31/2017
| Address |
98 Keji 6th Road
Zhuhai Guangdong 519085
China
|
|
Employees
|
- |
| Website |
http://www.jafron.com |
| Updated |
07/08/2019 |
| Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. Its products include single-use blood perfusion devices, blood perfusion machines, disposable plasma bilirubin adsorbers, and DX-10 blood purification machines. The company was founded on December 19, 1989 and is headquartered in Zhuhai, China. |
